Devjit Tripathy
Overview
Explore the profile of Devjit Tripathy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
4256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Gastaldelli A, Gaggini M, Daniele G, Ciociaro D, Cersosimo E, Tripathy D, et al.
Hepatology
. 2016 Sep;
64(6):2028-2037.
PMID: 27639082
Conclusion: Acute EX administration (1) improves Hep-IR, decreases EGP, and enhances HGU and (2) reduces Adipo-IR, improves the antilipolytic effect of insulin, and reduces plasma free fatty acid levels during...
22.
Guardado-Mendoza R, Chavez A, Jimenez-Ceja L, Hansis-Diarte A, DeFronzo R, Folli F, et al.
Acta Diabetol
. 2016 Sep;
54(1):53-61.
PMID: 27624579
Aims: Pancreatic islet amyloid deposition is a characteristic feature of type 2 diabetes mellitus (T2DM). Islet amyloid polypeptide (IAPP) is co-secreted with insulin, but its secretion profile and relationship to...
23.
Espinoza S, Wang C, Tripathy D, Clement S, Schwenke D, Banerji M, et al.
Age (Dordr)
. 2016 Sep;
38(5-6):485-493.
PMID: 27585671
To determine the efficacy of pioglitazone to prevent type 2 diabetes in older compared to younger adults with pre-diabetes. Six hundred two participants with impaired glucose tolerance (IGT) were randomized...
24.
Daniele G, Xiong J, Solis-Herrera C, Merovci A, Eldor R, Tripathy D, et al.
Diabetes Care
. 2016 Aug;
39(11):2036-2041.
PMID: 27561923
Objective: Insulin resistance is associated with mitochondrial dysfunction and decreased ATP synthesis. Treatment of individuals with type 2 diabetes mellitus (T2DM) with sodium-glucose transporter 2 inhibitors (SGLT2i) improves insulin sensitivity....
25.
Gelato M, Schoenfeld E, Hou W, Michalowicz B, Seaquist E, Oates T, et al.
Contemp Clin Trials
. 2016 Jul;
50:21-7.
PMID: 27417981
Objective: Evaluate the effect of medications and medication changes during the Diabetes and Periodontal Therapy Trial (DPTT) on the primary study outcome, namely, change in hemoglobin A1c (HbA1c) at 6months...
26.
Cowan T, Tripathy D, Oates T
Tex Dent J
. 2016 Mar;
133(1):18.
PMID: 27008840
No abstract available.
27.
Tripathy D, Schwenke D, Banerji M, Bray G, Buchanan T, Clement S, et al.
J Clin Endocrinol Metab
. 2016 Mar;
101(5):2056-62.
PMID: 26982008
Context: Thiazolidinediones have proven efficacy in preventing diabetes in high-risk individuals. However, the effect of thiazolidinediones on glucose tolerance after cessation of therapy is unclear. Objective: To examine the effect...
28.
Merovci A, Abdul-Ghani M, Mari A, Solis-Herrera C, Xiong J, Daniele G, et al.
J Clin Endocrinol Metab
. 2016 Jan;
101(3):1249-56.
PMID: 26765576
Aim: To investigate the effect of lowering the plasma glucose and free fatty acid (FFA) concentrations with dapagliflozin and acipimox, respectively, on insulin sensitivity and insulin secretion in T2DM individuals....
29.
Daniele G, Iozzo P, Molina-Carrion M, Lancaster J, Ciociaro D, Cersosimo E, et al.
Diabetes
. 2015 Jun;
64(10):3406-12.
PMID: 26116695
Glucagon-like peptide 1 receptors (GLP-1Rs) have been found in the brain, but whether GLP-1R agonists (GLP-1RAs) influence brain glucose metabolism is currently unknown. The study aim was to evaluate the...
30.
Daniele G, Winnier D, Mari A, Bruder J, Fourcaudot M, Pengou Z, et al.
Diabetes Care
. 2015 Jun;
38(8):1509-17.
PMID: 26084344
Objective: A gene mutation of the Wnt/β-catenin signaling cascade is present in rare patients with the insulin resistance syndrome. Sclerostin is a circulating peptide inhibiting Wnt/β-catenin signaling. Our aims were...